BamSEC and AlphaSense Join Forces
Learn More

Ventyx Biosciences Inc.

NASDAQ: VTYX    
Share price (10/16/25): $4.00    
Market cap (10/16/25): $285 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 4 pages Ventyx Biosciences, Inc. Amended and Restated Outside Director Compensation Policy Effective as of April 3, 2025
12/34/56
EX-10.7
from 10-K 6 pages Material contract
12/34/56
EX-10.5
from 10-Q 11 pages Consulting Agreement
12/34/56
EX-10.4
from 10-Q 4 pages July 2, 2024 Mark Forman, MD, Phd [***] via Electronic Mail Re: Employment Letter
12/34/56
EX-10.3
from 10-Q 3 pages December 1, 2022 Roy Gonzales [***] Dear Roy, on Behalf of Ventyx Biosciences, Inc. (The “Company”), I Am Pleased to Set Forth the Terms of Your Employment With the Company, Should You Accept Our Offer: 1
12/34/56
EX-10.2
from 10-Q 10 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 48 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Ventyx Biosciences, Inc. Amended and Restated Outside Director Compensation Policy Effective as of April 3, 2024
12/34/56
EX-10.1
from 8-K 5 pages May 1, 2024 Matthew Moore [***] [***] via Electronic Mail Re: Employment Letter Dear Matthew, This Employment Letter Agreement (The “Agreement”) Is Entered Into Between You and Ventyx Biosciences, Inc. (The “Company” or “We”), to Set Forth the Terms and Conditions of Your Employment With the Company
12/34/56
EX-10.1
from 8-K 13 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 52 pages Stock Purchase Agreement by and Between Ventyx Biosciences, Inc. and Each of the Purchasers as Set Forth Herein March 6, 2024
12/34/56
EX-10.2
from 8-K 19 pages Form of Registration Rights Agreement
12/34/56
EX-10.23
from 10-K 9 pages Consulting Agreement
12/34/56
EX-10.22
from 10-K 10 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 30 pages Sublease Agreement
12/34/56
EX-10
from 10-Q 4 pages Ventyx Biosciences, Inc. Amended and Restated Outside Director Compensation Policy Effective as of April 24, 2023
12/34/56
EX-10
from 10-K 4 pages Ventyx Biosciences, Inc. Outside Director Compensation Policy Adopted and Approved September 29, 2021, and Effective as of the Effective Date
12/34/56
EX-10
from 10-K 6 pages Ventyx Biosciences, Inc. Executive Incentive Compensation Plan
12/34/56
EX-10
from 10-K 35 pages Ventyx Biosciences, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 18 pages Form of Registration Rights Agreement
12/34/56